Current trends in whole blood and red cell therapy.
Modern blood bank technology has made available a variety of red cell and other blood products in addition to whole blood. The concept of component blood therapy should not discourage physicians from using whole blood in certain situations. The clinical indications for whole blood and red cell products are reviewed in this article.
D019794:2,3-Diphosphoglycerate; D001779:Blood Coagulation Factors; D001793:Blood Preservation / Q000379:methods; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002470:Cell Survival; D004163:Diphosphoglyceric Acids / Q000097:blood; D017707:Erythrocyte Transfusion; D005615:Freezing; D005990:Glycerol; D006400:Hematocrit; D006801:Humans; D016030:Kidney Transplantation
D001779:Blood Coagulation Factors; D004163:Diphosphoglyceric Acids; D019794:2,3-Diphosphoglycerate; D005990:Glycerol